Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

December 18, 2023

Study Completion Date

December 18, 2023

Conditions

Healthy Volunteer

Interventions

DRUG

Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet

Film-coated tablet administered orally.

DRUG

Lumacaftor 200 mg Film-Coated Tablet Formulation

Film-coated tablet administered orally.

Trial Locations (1)

BioPharma Services Inc., Toronto

All Listed Sponsors

lead

Qanatpharma Canada LTD

INDUSTRY

NCT05968612 - Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets | Biotech Hunter | Biotech Hunter